Jonathan Milner

Jonathan Milner Overview

Investor Type Angel
Status Active
Professionals 1
Professionals
Investments 32
Portfolio 18
Exits 4
Exits

Jonathan Milner General Information

Description

Dr. Jonathan Milner is a Co-Founder and serves as Chairman at Axol Biosciences. Dr. Milner also serves as Chairman & Company Director at PhoreMost. He also serves as Lead investor and Non-Executive Director at SyndicateRoom and as Non-Executive Director at Repositive. Currently, he also served as Co-Chairman & Board Member at DefiniGEN. He is a Co-Founder and serves as Director, Deputy Chairman at Abcam and Chairman at GeneAdviser. He also serves as the Board Member at Horizon Discovery. He also serves as Member of Advisory Panel at Cambridge Innovation Capital. Jonathan is an experienced entrepreneur and business leader with a background in genetic research. He is an active supporter of the Cambridge business community, is a founder of Abcam and chairman of Cambridge Temperature Concepts (CTC). Jonathan gained his doctorate in Molecular Genetics at Leicester University after graduating in Applied Biology at Bath University.

Contact Information

Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)
Primary Office
  • Cambridge
  • England, United Kingdom

Jonathan Milner Investments (32)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Spirea (Drug Delivery) 17-Apr-2020 Early Stage VC 00000 Drug Delivery Startup 00000000 000000 00.0
000000 00000000000 15-Feb-2020 0000 00000 00000 Other Healthcare Technology Systems Startup 00000000 000000 00.0
0000 00000000000 15-Jan-2020 0000 00000 00.000 Biotechnology Generating Revenue 00000000 000000 00.0
00000 (00000000000 29-Oct-2019 00000 00000 000.00 Diagnostic Equipment Generating Revenue 00000000 000000 00.0
00000 16-Oct-2019 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2 00000000 000000 00.0
00000 00000 23-Apr-2019 0000 00000 Financial Software Generating Revenue 00000000 000000 00.0
00000000 29-Mar-2019 00000 00000 000.00 Business/Productivity Software Generating Revenue 00000000 000000 00.0
00000 26-Jul-2018 00000 00000 00.00 Drug Discovery Clinical Trials - Phase 2 00000000 000000 00.0
PhoreMost 30-Apr-2018 Early Stage VC 000.00 Drug Discovery Product Development 00000000 000000 00.0
Crayfish 12-Mar-2018 Early Stage VC 00000 Business/Productivity Software Startup 00000000 000000 00.0
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Jonathan Milner Exits (4)

To view Jonathan Milner‘s complete exit history, request access »
Company Name Exit Date Exit Type Exit Size
Desktop Genetics 01-Jun-2018 Merger/Acquisition
00000000000 21-Jun-2017 000 00 00000000
Oval Medical Technologies 13-Dec-2016 Merger/Acquisition
Horizon Discovery 27-Mar-2014 IPO 00000

Jonathan Milner Team (1)

Name Title Deals Funds Boards Office
Jonathan Milner Ph.D Angel Investor 00 0 Cambridge, United Kingdom